10,808,039) covering ADCs that include auristatin compounds coupled to an antibody via a linker molecule ... It also said the US Patent and Trademark Office has granted a request to review ...
The small molecule active pharmaceutical ingredient market has shown strong growth, increasing from $181.54 billion in 2023 to $196.44 billion in 2024 at a CAGR of 8.2%. Growth factors include ...
Empyrean Therapeutics acquires TLR-2 antagonist molecule from Eos Therapies to advance and commercialize breakthrough cancer treatment: Boca Raton, Florida Wednesday, November 27, ...
A research article shows that Eradivir's patent-pending antiviral therapeutic called EV25 reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than ...
The EMS-312 molecule has been recently granted patents in all major global markets. Both companies collaborate closely to seamlessly transition all intellectual property, associated research data ...